
|Articles|December 2, 2004
- Pharmaceutical Technology-12-02-2004
- Volume 28
- Issue 11
Safety Problems Roil Pharma and FDA
Author(s)Jill Wechsler
Blockbuster drugs turn out to be risky business, while contamination problems shut down flu vaccine production.
Advertisement
Articles in this issue
about 21 years ago
In the Spotlight-December 2004about 21 years ago
December 2004about 21 years ago
Robust CRO Market Is Driving New Merger and Acquisition Activityabout 21 years ago
The Seventh Annual International Employment Surveyabout 21 years ago
Pharmaco-FakeryNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
2
Women in STEM: Early Phase Drug Development
3
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
4
PharmTech Weekly Roundup - February 6, 2026
5




